Equity
Total Equity
Boston Scientific Total Equity increased by 6.7% to $25.86B in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 16.4%, from $22.21B to $25.86B. Over 5 years (FY 2020 to FY 2025), Total Equity shows an upward trend with a 9.6% CAGR. This is a positive signal — higher values indicate stronger performance for this metric.
Analysis
StatementBalance Sheet Statement
SectionEquity
CategoryCapital Allocation
SignalHigher is better
VolatilityModerate
First reportedQ4 2015
Last reportedQ1 2026May 1, 2026
How to read this metric
Growth in equity generally signals value creation, while a decline may indicate asset impairment or excessive debt-funded buybacks.
Detailed definition
The residual interest in the assets of the entity after deducting liabilities. It represents the net book value of the c...
Peer comparison
Used to calculate Return on Equity (ROE) for benchmarking against industry peers.
Metric ID:
total_stockholders_equityHistorical Data
20 periods
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $15.94B | $16.46B | $16.62B | $16.74B | $17.25B | $17.64B | $17.57B | $17.85B | $18.23B | $18.89B | $19.28B | $19.93B | $20.37B | $20.71B | $21.77B | $22.21B | $22.42B | $23.39B | $24.23B | $25.86B |
| QoQ Change | — | +3.3% | +1.0% | +0.7% | +3.1% | +2.3% | -0.4% | +1.6% | +2.1% | +3.6% | +2.1% | +3.3% | +2.2% | +1.7% | +5.1% | +2.0% | +0.9% | +4.4% | +3.6% | +6.7% |
| YoY Change | — | — | — | — | +8.2% | +7.2% | +5.7% | +6.7% | +5.7% | +7.1% | +9.7% | +11.6% | +11.8% | +9.6% | +12.9% | +11.5% | +10.0% | +13.0% | +11.3% | +16.4% |
Range$15.94B – $25.86B
CAGR+10.7%
Avg YoY Growth+9.9%
Median YoY Growth+9.9%
Current Streak13 quarters growth
Total Equity at Other Companies
Frequently Asked Questions
- What is Boston Scientific's total equity?
- Boston Scientific (BSX) reported total equity of $25.86B in Q1 2026.
- How has Boston Scientific's total equity changed year-over-year?
- Boston Scientific's total equity increased by 16.4% year-over-year, from $22.21B to $25.86B.
- What is the long-term trend for Boston Scientific's total equity?
- Over 5 years (2020 to 2025), Boston Scientific's total equity has grown at a 9.6% compound annual growth rate (CAGR), from $15.33B to $24.23B.
- What does total equity mean?
- The total net value of the company belonging to shareholders.